CHICAGO--(BUSINESS WIRE)--Neuroscience 2009-–PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the introduction of several new tools to improve the speed and effectiveness of research for neurological disorders such as Alzheimer’s, Parkinson’s, multiple sclerosis and other central nervous system disorders.
